Skip to main content
. 2020 May 18;123(3):378–391. doi: 10.1038/s41416-020-0891-x

Fig. 1. Expression of CDK4/6 in GCT tissues and cell lines.

Fig. 1

a Analysis of CDK4/6 expression in GCT tissues (type II GCTs, upper panel, Affymetrix microarray; type I GCTs, inlay in upper panel, qRT-PCR) and cell lines (middle panel: Illumina microarray; lower panel: RNA-seq data, RPKM = reads per kilobase million). As controls, normal testis tissue (NTT), the Sertoli cell line FS1 and fibroblasts (MPAF) were included. Standard deviation is given above bars. b Western blot analysis of CDK4, CDK6, RB1 and phospho-RB1 (pRB1) protein levels in GCT cell lines and controls (fibroblasts, Sertoli cells). HepG2 and HeLa cells served as positive controls for CDK4 and CDK6. GAPDH was used as housekeeper and for normalisation. c Immunohistochemical staining of CDK4 in GCT tissues (seminoma, EC, yolk-sac tumour and teratoma). Scale bar: 500 μm.